Dr. Schowinsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aip Mail Stop F768
Aurora, CO 80045Phone+1 720-848-4411Fax+1 720-848-4454
Education & Training
Johns Hopkins UniversityFellowship, Hematopathology, 2007 - 2008- Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2003 - 2007
Medical College of WisconsinClass of 2003
Certifications & Licensure
CO State Medical License 2009 - 2025
IA State Medical License 2008 - 2011
PA State Medical License 2006 - 2008- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 94 citationsVenetoclax and Azacitidine Compared to Induction Chemotherapy for Newly Diagnosed Patients with Acute Myeloid Leukemia.Evan Cherry, Diana Abbott, Maria L. Amaya, Christine McMahon, Marc Schwartz
Blood Advances. 2021-10-05 - 79 citationsUpdate on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab.Bette K. Kleinschmidt-DeMasters, Augusto Miravalle, Jeffrey Schowinsky, John R. Corboy, Timothy Vollmer
Journal of Neuropathology and Experimental Neurology. 2012-07-01 - 16 citationsNatalizumab-associated complication? First case of peripheral T cell lymphoma.Jeffrey Schowinsky, John R. Corboy, Timothy Vollmer, Bette K. Kleinschmidt-DeMasters
Acta Neuropathologica. 2012-03-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
